-
-
Overview
-
PRL-3195 [H-Phe(4-Cl)-D-Cys-β-(3-pyridyl)-Ala-D-Trp-N-Me-Lys-Thr-Cys-2-Nal-NH2] is a peptide compound acting as a somatostatin receptor antagonist. It inhibits human somatostatin receptors with Kis of 6, 17, 66, 1000 and 1000 nM for sst5, sst2, sst3, sst1 and sst4, respectively.
Please contact us at for specific academic pricing.
-
- Properties
-
Overview